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Background: Genome-wide association studies (GWAS) are useful to reveal an association between single
nucleotide polymorphisms and different measures of obesity. A multitude of new loci has recently been reported,
but the exact function of most of the according genes is not known. The aim of our study was to start elucidating
the function of some of these genes.
Methods: We performed an expression analysis of fourteen genes, namely BDNF, ETV5, FAIM2, FTO, GNPDA2,
KCTD15, LYPLAL1, MCR4, MTCH2, NEGR1, NRXN3, TMEM18, SEC16B and TFAP2B, via real-time RT-PCR in adipose
tissue of the kidney capsule, the mesenterium and subcutaneum as well as the hypothalamus of obese Zucker
diabetic fatty (ZDF) and Zucker lean (ZL) rats at an age of 22 weeks.
Results: All of our target genes except for SEC16B showed the highest expression in the hypothalamus. This
suggests a critical role of these obesity-related genes in the central regulation of energy balance. Interestingly, the
expression pattern in the hypothalamus showed no differences between obese ZDF and lean ZL rats. However,
LYPLAL1, TFAP2B, SEC16B and FAIM2 were significantly lower expressed in the kidney fat of ZDF than ZL rats.
NEGR1 was even lower expressed in subcutaneous and mesenterial fat, while MTCH2 was higher expressed in the
subcutaneous and mesenterial fat of ZDF rats.
Conclusion: The expression pattern of the investigated obesity genes implies for most of them a role in the central
regulation of energy balance, but for some also a role in the adipose tissue itself. For the development of the ZDF
phenotype peripheral rather than central mechanisms of the investigated genes seem to be relevant.
Keywords: BDNF, ETV5, FAIM2, FTO, GNPDA2, KCTD15, LYPLAL1, MCR4, MTCH2, NEGR1, NRXN3, TMEM18, SEC16B,
TFAP2B, ZDF-ratsBackground
By now, overweight and obesity have become a major
public health problem in the industrialized world and
also in developing countries. Both result in an increased
morbidity and mortality, not to mention the financial
costs for the health-care systems. According to the
World Health Organisation (WHO) in 2005 worldwide
at least 400 million adults were obese and this count is
expected to rise to 700 million until 2015 (http://www.
who.int/gho/ncd/risk_factors/overweight/en/). Thereby,* Correspondence: peterm.schmid@ukr.de
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reproduction in any medium, provided the orlifestyle changes with an increased intake of energy-
dense foods and a trend to decreased physical activity
are fundamental causes for this rise to epidemic propor-
tions, but heritability studies provide evidence for a not-
able genetic involvement [1,2].
Genome-wide association studies (GWAS) are excel-
lently qualified to reveal single genetic polymorphisms
associated with human obesity, but they allow no conclu-
sions about the function of the affected genes. Since re-
cent GWAS [3-11] in adults could find different genetic
loci located next to or in so far partly unknown genes,
now the physiologic role of most of these genes has to
be elucidated.
The aim of our study was to shed some light in the role
of fourteen recently described genes, namely BDNF,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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MCR4, MTCH2, NEGR1, NRXN3, TMEM18, SEC16B,
and TFAP2B, which were associated with different mea-
sures of human obesity. Thereby, as a first step it is rea-
sonable to identify tissues, in which those genes are
expressed, and to reveal differences in the expression levels
between obese and lean subjects. Therefore our study was
planned as a descriptive expression analysis of these obes-
ity-related genes in an animal model of diabetes mellitus
type 2 and obesity, the ZDF rat, in comparison to their
lean normoglycemic littermate, the ZL rat.
Some of the obesity-genes are already known to regu-
late energy homeostasis and for some others it is shown
that they are expressed in the central nervous system
[11] and may influence energy expenditure centrally in
the hypothalamus. For other genes functions apart from
the regulation of energy homeostasis are described and
for some genes their function is totally unknown. Since
the adipose tissue is not only a simple energy storage,
but also a key regulator of body weight [12,13], it is also
a possible location of action for these obesity-related
genes. Thereby, it is important to differentiate between
adipose tissues of different origin as it is known that es-
pecially mesenterial adipose tissue harbors a high risk for
comorbidities like diabetes mellitus type 2 and athero-
sclerosis [14]. Therefore the gene expression was mea-
sured via real-time RT-PCR in the hypothalamus as
regulatory center of energy balance and food intake [15]
and in the adipose tissue of the mesenterium, the subcu-
taneum and the kidney capsule.
Methods
Animal experiment
The study was approved by the local committee on ani-
mal research and is in accordance with the “Guide for
the Care and Use of Laboratory Animals’ published by
the US National Institutes of Health. The EU legislation
for animal care (86/609/CEE) was applied. Six male
Zucker diabetic fatty (ZDF) rats (fa/fa) and six male
Zucker lean rats (fa/-) (ZL) were studied from an age of
13 weeks until an age of 24 weeks. The animals were in-
dividually housed on a 12-hour dark/12-hour light cycle.
They were fed a Purina 5008 rat chow containing 23%
protein, 6.5% fat, 58.5% carbohydrates, 4% fiber and 8%
ash. Rats received tap water ad libitum. In week 14 and
22 systolic blood pressure was assessed by tail cuff
method using an automated cuff inflator-pulse detection
system (CODA2 Multi-Channel, Computerized, EMKA
TECHNOLOGIES, Paris, France). At the same time-
points the animals were weighted and blood glucose was
measured after 6 hours fasting (ACCU-CHEK Sensor,
Roche GmbH, Mannheim, Germany). Animals were
sacrificed at 24 weeks of age and we prepared the adi-
pose tissue of the mesenterium (mesenterial fat, MF), thekidney capsule (kidney fat, KF) and subcutaneum
(subcutaneous fat, SF) as well as the hypothalamus (HT)
of the six ZDF and ZL rats. Serum levels of leptin and
adiponectin as marker of obesity were determined via
ELISA according to the manufacturers instructions
(B-Bridge International, Inc., 5 Mountain View, USA).
Expression analysis via real-time RT-PCR
The fourteen target genes were chosen according to the
results of recent GWAS and metaanalysis of GWAS
[4-11], in which they were found to be significantly asso-
ciated with different measures of obesity. The gene ex-
pression was measured in three different adipose tissues
(KF (kidney fat), SF (subcutaneous fat) and MF (mesen-
terial fat)) and the hypothalamus (HT) by using the real-
time RT-PCR technique. Therefore total RNA from the
different tissues was extracted using the RNeasy kit
(Quiagen, Hilden, Germany) according to the manufac-
turers instructions. A DNase digestion step was included.
For first-strand cDNA synthesis, 1 μg total RNA was re-
verse transcribed with 1U MMLV Reverse Transcriptase,
1 μg Random Primer, 1 mM deoxynucleotide triphos-
phate mixture, 1 μl recombinant RNasin W ribonuclease
inhibitor and transcription buffer with 5 mM MgCl2 in a
final volume of 10 μl (all from Promega, Mannheim,
Germany). The reaction mixture was incubated at 37°C
for 60 min, followed by heat inactivation of the enzyme
at 95°C for 5 min. After cooling on ice for 5 min, the
cDNA was stored at −20°C until further use. Real-time
RT-PCR detection of the target genes and beta-actin as
housekeeping gene was perfomed using the AbiPrism
7900 TaqMan (Applied Biosystems, Foster City; CA,
USA). Primers and probes (Table 1) were used according
to the manufacturer’s protocol (Applied Biosystems).
The expression levels of the target mRNA were normal-
ized to beta-actin using the DeltaCt method. Parallelism
of amplification curves of the target and control was
confirmed.
Statistical analysis
The means of every measurement for the biometric data
of ZL and ZDF rats as well as the means of the expres-
sion data from the real-time RT-PCR were calculated for
each tissue sample and animal group. Groups were com-
pared using the Students t test or one-way ANOVA as
appropriate. A p-value of <0.05 was considered to be
significant. The biometric data are presented as means ±
SEM, the expression data are depicted in graphics with
an arbitrary logarithmic y-axis as means + StdDev.
Results and discussion
Biometric data of ZL and ZDF rats
In Table 2 the biometric data of ZL and ZDF rats at an
age of 22 weeks are summarized. As expected, ZDF rats
Table 2 Biometric data of ZL and ZDF rats at an age of
22 weeks
Parameters Week 22
ZL (n = 6) ZDF (n = 6) p
Blood glucose [mg/dl] 87 ± 1 393 ± 19 <0.001
SBP [mmHg] 119 ± 5 99 ± 2 0.003
Body weight [g] 405 ± 9 376 ± 4 0.01
Tibia length [cm] 4.5 ± 0.04 4.3 ± 0.03 0.008
Leptin [ng/ml] 10.3 ± 0.6 15.4 ± 1.6 0.013
Adiponectin [μg/ml] 23.0 ± 1.8 15.7 ± 0.6 0.003
Values are mean± SEM. SBP indicates systolic blood pressure.
Table 1 Primer and probes
Gene symbol Gene name Applied biosystems
assay ID
Actb Beta Actin Rn00667869_m1
BDNF Brain derived neurotrophic factor Rn02531967_s1
ETV5 Ets variant 5 Rn00465814_g1
FAIM2 Fas apoptotic inhibitory molecule 2 Rn01532650_m1
FTO FTO Rn01538183_m1
GNPDA2 Glucosamine-6-phosphate
deaminase 2
Rn01413702_m1
LYPLAL1 Lysophospholipase-like 1 Rn01411856_g1
MC4R Melanocortin 4 receptor Rn01491866_s1
MTCH2 Mitochondrial carrier homolog 2 Rn01013168_m1
NRXN3 Neurexin 3 Rn00587546_m1
NEGR1 Neuronal growth regulator 1 Rn00572380_m1
KCTD15 Potassium channel tetramerisation
domain containing 15
Rn01458149_m1
SEC16B SEC16 homolog B Rn00585728_m1
TFAP2B Transcription factor AP-2 beta Rn01511928_m1
TMEM18 Transmembrane protein 18 Rn01473465_g1
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elevated blood glucose, while the ZL rats were normogly-
cemic. The blood pressure was lower in the ZDF rats in
terms of an advanced stage of disease. Surprisingly, the
ZL rats weighted significantly more than the diabetic
ZDF rats, but that was due to a better growth during the
animal experiment, which was represented in a signifi-
cantly greater tibia length in ZL rats. However the ZDF
rats apparently had a different body composition with a
smaller size and a higher body fat portion. This is also
reflected by significantly higher serum levels of leptin
and lower serum levels of adiponectin in ZDF rats.
Genes with a known role in regulation of energy
homeostasis
FTO (fat mass and obesity associated, Figure 1a) was the
first gene of the GWAS era, which was found to be asso-
ciated with obesity [16], and therefore is one of the best
investigated obesity-gene [17]. It is highly expressed in
the arcuate nucleus of the hypothalamus and is supposed
to have an anorexigenic function since an overexpression
of FTO in the hypothalamus decreases and a knock-
down of FTO increases food intake [18]. In our study
the greatest amount of FTO mRNA in both animals was
detected in the hypothalamus with significant differences
to the other tissues (ZL and ZDF: p< 0.001 for HT vs
KF, SF and MF). Only in ZL rats the expression in sub-
cutaneous fat was significantly lower than in kidney and
mesenterial fat (p= 0.001 for SF vs KF, p= 0.037 for SF vs
MF), in ZDF rats the expression in the fat tissues was
equally high. Significant changes between the animal
groups for a single tissue could not be detected.MC4R (melanocortin 4 receptor, Figure 1b) as part of
the central melanocortin system is highly expressed in
the hypothalamus and mutations in the gene are thought
to be a reason for obesity [19]. α-melanocyte stimulating
hormone binds to MC4R in the hypothalamus, which
leads to an enhancement of anorexigenic and an inhib-
ition of orexigenic stimuli [20]. MC4R knock-out mice
show the phenotype of the so called melanocortin obes-
ity syndrome consisting of hyperphagia, hypometabo-
lism, hyperinsulinemia and increased linear growth
[21,22]. Generally, the central melanocortin system is
accepted to be a key regulator of energy homeostasis and
food intake, it affects body composition and diverse sig-
nals for the regulation of energy homeostasis like leptin
interact with it [23]. The expression of MC4R showed
the highest levels in the hypothalamus and mesenterial
fat of ZL as well as ZDF rats. In kidney and subcutane-
ous fat the amount was significantly lower than in the
hypothalamus and mesenterial fat (ZL: p< 0.001 for MF
vs. KF, p= 0.001 for MF vs. SF, p< 0.001 for HT vs. KF,
p= 0.002 for HT vs. SF; ZDF: p= 0.007 for MF vs. KF,
p= 0.009 for MF vs. SF, p< 0.001 for HT vs. KF and SF).
Comparing each single tissue between ZL and ZDF rats
no significant difference could be found.
BDNF (brain derived neurotrophic factor, Figure 1c)
as nerve growth factor is widely distributed throughout
the whole brain [24]. Recently, BDNF was also sug-
gested to be an important effector of the melanocortin
system since BDNF infusion in the brain suppressed
hyperphagia and weight gain in MC4R deficient mice
[25]. For BDNF the expression level was similar high in
the hypothalamus and mesenterial fat of ZL and ZDF
rats each with significant differences to the other fat tis-
sues (ZL and ZDF: p< 0.001 for HT vs. KF and SF,
p< 0.001 for HT vs. MF). A significant difference be-
tween kidney fat and subcutaneous fat was not detected
in both animal groups. Also, there were no significant
differences between ZL and ZDF rats for a special
tissue.
In summary, our data support the known role of these
genes in the central regulation of energy balance even in
Figure 1 Expression of genes with a known role in regulation of energy homeostasis. a) Relative expression of FTO. * p< 0.05 vs. ZL KF, ZL
SF and ZL MF; † p< 0.05 vs. ZL KF, ZL MF and ZL HT; # p< 0.05 vs. ZDF KF, ZDF SF and ZDF MF. b) Relative expression of MC4R. * p< 0.05 vs. ZL
KF, ZL SF and ZL MF; † p< 0.05 vs. ZDF KF, ZDF SF and ZDF MF. c) Relative expression of BDNF. * p< 0.05 vs. ZL KF and ZL SF; † p< 0.05 vs. ZDF
KF and ZDF SF.
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BDNF in the mesenterial fat suggests also a possible dir-
ect action of the melanocortin system in the adipose
tissue.Genes with a known neuronal expression
TMEM18 (transmembrane protein 18, Figure 2a) was re-
cently found to be remarkably conserved across different
species and to be expressed in many brain sites without
Figure 2 Expression of genes with a known neuronal
expression. a) Relative expression of TMEM18. * p< 0.05 vs. ZL KF,
ZL SF and ZL MF; † p< 0.05 vs. ZDF KF, ZDF SF and ZDF MF. b)
Relative expression of KCTD15. * p< 0.05 vs. ZL KF and ZL SF; †
p< 0.05 vs. ZDF KF and ZDF SF. c) Relative expression of NEGR1.
* p< 0.05 vs. ZL KF, ZL SF and ZL MF; † p< 0.05 vs. ZDF KF, ZDF SF
and ZDF MF; # p< 0.05 vs. ZDF KF; } p< 0.05 vs. ZDF SF; { p< 0.05
vs. ZDF MF. d) Relative expression of NRXN3. No detectable mRNA-
amount in adipose tissues.
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expression pattern of TMEM18 in ZL and ZDF rats was
similar without significant differences between each single
tissues of the two animal groups. The highest amount of
TMEM18 mRNA was found in the hypothalamus of both
animals with significant differences to the different fat tis-
sues (ZL and ZDF: p< 0.001 for HT vs KF, SF and MF).
KCTD15 (potassium channel tetramerisation domain
containing 15, Figure 2b) is a BTB domain-containing
protein and inhibits neural crest induction [27]. The
highest quantitiy of KCTD15 mRNA was found for ZL
and ZDF rats in mesenterial fat and the hypothalamus.
Herein, the quantity was significantly higher than in kid-
ney and subcutaneous fat (ZL: p< 0.001 for MF and HT
vs KF and SF; ZDF: p= 0.008 for MF vs KF, p= 0.012 for
MF vs SF, p= 0.009 for HT vs KF, p= 0.013 for HT vs SF).
Significant differences for each single tissues between the
two animal groups were not detected.
NEGR1 (neuronal growth regulator 1, neurotractin,
Figure 2c) seems to play an important role in neuronal
outgrowth during neurogenesis [28,29]. For both animal
groups the quantity of NEGR1 mRNA was highest in the
hypothalamus (ZL and ZDF: p< 0.001 for HT vs. KF, SF
and MF). Interestingly, there were also significant differ-
ences between all three adipose tissues of ZL and ZDF
rats. In kidney, subcutaneous and mesenterial fat the ex-
pression was significantly higher in ZL than in ZDF rats
(KF: p= 0.002 for ZL vs. ZDF, SF: p= 0.027 for ZL vs
ZDF, MF: p= 0.013 for ZL vs. ZDF).
NRXN3 (neurexin 3, Figure 2d) seems to play an im-
portant role in psychiatric disorders and recently it was
also found to be expressed in other tissues like the heart
[30]. The only tissue, in which mRNA of NRXN3 was de-
tectable, was the hypothalamus of ZL and ZDF rats with
no significant differences between the two animal groups.
Summing up, for TMEM18, KCTD15, NEGR1 and
NRXN3 a neuronal expression is known and therefore a
potential central effect on energy homeostasis is possible,
but so far not yet described. Our data are in line with previ-
ous findings of the central expression of these genes. Re-
cently, for NEGR1 additionally a differential expression
between obese and lean siblings in subcutaneous fat was
described and a central function in an obesity-related tran-
script network was suggested [31]. In our work, we could
also show significant changes between obese and lean rats
not only in the subcutaneous fat, but also in the kidney and
mesenterial fat. This implicates a possible role of NEGR1 in
the regulation of obesity in the adipose tissue itself and es-
pecially in the development of the ZDF phenotype.
Genes with functions so far apart from the regulation
of energy homeostasis
Mutations of TFAP2B (transcription factor activating
enhancer binding protein 2 beta, Figure 3a) are known
Figure 3 Expression of genes with functions so far apart from the regulation of energy homeostasis. a) Relative expression of TFAP2B.
* p< 0.05 vs. ZL KF and ZL MF; † p< 0.05 vs. ZDF KF and ZDF MF; # p< 0.05 vs. ZDF KF. b) Relative expression of ETV5. * p< 0.05 vs. ZL KF, ZL SF
and ZL MF; † p< 0.05 vs. ZL HT and ZL MF; # p< 0.05 vs. ZDF KF and ZDF SF. c) Relative expression of MTCH2. * p< 0.05 vs. ZL KF, ZL MF and ZL
HT; † p< 0.05 vs. ZL KF and ZL HT; # p< 0.05 vs. ZDF KF, ZDF SF and ZDF HT; } p< 0.05 vs. ZDF SF; { p< 0.05 vs. ZDF MF.
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could also show an expression in visceral and subcutane-
ous fat without a correlation to the body mass index orrisk of diabetes mellitus type 2 in humans [34]. However,
a negative correlation with the expression of adiponectin
and leptin was found, which suggests that TFAP2B may
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study the expression pattern of TFAP2 was similar be-
tween ZL and ZDF rats, each with highest expression in
the hypothalamus and subcutaneous fat (ZL: p< 0.001
for HT vs. KF and MF, p= 0.003 for SF vs. KF, p= 0.021
for SF vs. MF; ZDF: p< 0.001 for HT vs. KF and MF, p
< 0.001 for SF vs. KF and MF). In ZL rats the difference
between hypothalamus and subcutaneous fat (p= 0.055)
and in ZDF rats the difference between kidney and
mesenterial fat (p= 0.051) did barely not reach the sig-
nificance level. Comparing each single tissue between ZL
and ZDF rats a significant higher expression level was
only found in the kidney fat for lean animals. So, our
results confirm the expression of TFAP2B in adipose tis-
sues especially the subcutaneous fat, where it was equally
high expressed as in the hypothalamus. Additionally, we
could find that the expression of TFAP2B was not differ-
ent between obese ZDF and lean ZL rats in the mesen-
terial and subcutaneous fat, but was significantly lower
in the kidney fat of ZDF rats.
ETV5 (ets variant 5, Figure 3b) was until now mainly
known to be an essential transcription factor for the es-
tablishment of the spermatogonial stem cell pool and its
subsequent self-renewal and maintenance [36]. The ex-
pression pattern in our study of ZL and ZDF rats was
quite similar without significant differences between the
animal models for each tissue. Overall the highest ex-
pression was detected in the hypothalamus. In ZL rats
the difference between hypothalamus and the adipose
tissues was significantly (p< 0.001 for HT vs. KF,
p= 0.007 for HT vs. SF, p= 0.037 for HT vs. MF) and also
the expression in mesenterial fat was higher than in kid-
ney fat (p= 0.018). For ZDF rats the amount of ETV5
mRNA in the hypothalamus was significantly greater
than in the kidney fat and subcutaneous fat (p< 0.001
for HT vs. KF and SF), but slightly missed the signifi-
cance level versus mesenterial fat (p= 0.058). In mesen-
terial fat it was significantly higher expressed than in
kidney and subcutaneous fat (p< 0.001 for MF vs. KF,
p= 0.005 for MF vs. SF). Herewith, our results reveal a
so far not described high expression of ETV5 in the
hypothalamus, which suggests a possible role in the cen-
tral regulation of energy balance.
MTCH2 (mitochondrial carrier 2, Figure 3c) is a mito-
chondrial membrane protein and seems to regulate cell
proliferation and apoptosis [37,38]. Lately, a high expres-
sion of MTCH2 was described in adipose tissue. It could
be shown that the expression was higher in subcutane-
ous fat than in visceral fat and that the expression of
MTCH2 was higher in obese than in lean women [39].
In our investigation the expression of MTCH2 was low-
est in mesenterial fat of ZL and ZDF rats (ZL and ZDF: p
< 0.001 for MF vs. KF, SF and HT). In ZDF animals the
expression in the other three tissues was similar high,only in ZL rats the expression in the subcutaneous fat
was lower than in the kidney fat and the hypothalamus
(p< 0.001 for SF vs. KF, p= 0.001 for SF vs HT). In com-
parison of each single tissue between lean and obese ani-
mals the expression of MTCH2 in the subcutaneous
(p= 0.017) and the mesenterial fat (p= 0.014) was signifi-
cantly higher in ZDF rats. Therewith, our data are in line
with aforementioned studies showing a higher expression
of MTCH2 in the subcutaneous fat than in mesenterial
fat und also finding a higher expression in obese ZDF
rats than in lean ZL rats. However, a new finding is the
high expression in the hypothalamus of both animal
groups. Therefore MTCH2 may play an important role
in central and peripheral regulation of obesity.
Genes with unknown functions
The function of the GWAS obesity-related genes
GNPDA2, FAIM2 and LYPLAL1 is to our knowledge
mainly unkown and we report here the first expression
data for these genes in comparison between obese and
lean animals.
The expression of GNPDA2 (glucosamine 6 phosphate
deaminase 2, Figure 4a) was for both animal models
highest in the hypothalamus with significant differences
to the fat tissues (ZL: p< 0.001 for HT vs. KF, SF and
MF; ZDF: p= 0.008 for HT vs. KF, p= 0.001 for HT vs.
SF, p= 0.006 for HT vs MF). The expression in kidney,
subcutaneous and mesenterial fat was at similar levels
with no differences between the ZL and ZDF rats.
For FAIM2 (fas apoptotic inhibitory molecule 2,
Figure 4b) the highest expression was observed for obese
and lean animals in the hypothalamus with significant dif-
ferences to the various fat tissues (ZL and ZDF: p< 0.001
for HT vs. KF, SF and MF). Whereas for ZDF rats the ex-
pression in the fat tissues was at the same level, it was sig-
nificantly lower in mesenterial fat of ZL rats in comparison
to the other fat tissues (p=0.023 for MF vs. SF, p=0.032
for MF vs. KF). Comparing each single tissues between
both animal groups only in kidney fat a significantly de-
crease was detected in ZDF rats (p=0.021).
Looking at ZL rats, the lowest expression of LYPLAL1
(lysophospholipase like 1, Figure 4c) was found in
mesenterial fat with significant differences to all other
tissue samples (p <0.001 for MF vs. SF, KF and HT).
Highest levels were seen in the hypothalamus and kidney
fat (p< 0.001 for HT vs. SF, p< 0.001 for KF vs. SF). In
ZDF rats the expression pattern was quite similar, only
the expression in kidney fat was significantly lower than
in ZL rats (p= 0.017), which resulted in a similar quan-
tity to that of subcutaneous fat (p= 0.026 for MF vs. SF,
p= 0.012 for MF vs. KF, p< 0.001 for MF vs HT,
p= 0.020 for HT vs SF, p= 0.045 for HT vs. KF).
For SEC16B (SEC16 homolog B, Figure 4d) in ZL rats
the highest expression was found in the subcutaneous fat
Figure 4 Expression of genes with unknown functions. a) Relative expression of GNPDA2. * p< 0.05 vs. ZL KF, ZL SF and ZL MF; † p< 0.05 vs.
ZDF KF, ZDF SF and ZDF MF. b) Relative expression of FAIM2. * p< 0.05 vs. ZL KF, ZL SF and ZL MF; † p< 0.05 vs. ZL KF, ZL MF and ZL HT; #
p< 0.05 vs. ZDF KF, ZDF SF and ZDF MF; } p< 0.05 vs. ZDF KF. c) Relative expression of LYPLAL1. * p< 0.05 vs. ZL SF and ZL MF; † p< 0.05 vs. ZL
KF, ZL MF and ZL HT; # p< 0.05 vs. ZDF MF and ZDF HT; } p< 0.05 vs. ZDF KF, ZDF SF and ZDF MF; { p< 0.05 vs ZDF KF. d) Relative expression
of SEC16B. * p< 0.05 vs. ZL KF, ZL MF and ZL HT; † p< 0.05 vs. ZL KF and ZL MF; # p< 0.05 vs. ZDF MF and ZDF HT; } p< 0.05 vs. ZDF KF.
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for SF vs. MF, KF and HT) and lowest in the hypothal-
amus with significant differences to the kidney and
mesenterial fat (p= 0.008 for HT vs KF, p< 0.001 for HT
vs. MF). In ZDF rats the pattern was quite similar (p
< 0.001 for SF vs. KF and HT, p= 0.003 for MF vs. HT,
p= 0.011 for MF vs KF), although the difference between
subcutaneous and mesenterial fat slightly failed the sig-
nificance level (p= 0.059). In the kidney fat the expres-
sion in ZL rats was significantly higher than in the ZDF
rats (p= 0.010).
Taking together, whereas the high expression of these
genes with unknown function in the hypothalamus again
suggests a role in central energy regulation, LYPLAL1
with its notable expression in the kidney fat and the dif-
ferences between ZDF and ZL rats implicates also a role
in the adipose tissue itself. SEC16B was the only investi-
gated gene that showed the highest expression not in the
hypothalamus. Its function is mainly unknown, but it
was highest expressed in the subcutaneous fat alone,
which indicates a possible role in the peripheral regula-
tion of obesity.
In summary, our results show that all of the fourteen
target genes are expressed in the hypothalamus and in
the investigated adipose tissues. The only exception was
NRXN3, which was exclusively expressed in the hypo-
thalamus and not in the adipose tissues. Likewise,
TMEM18, NEGR1, GNPDA2, FTO, FAIM2 and ETV5
showed the highest expression in the hypothalamus. The
highest expression for MC4R, KCTD15, BDNF,
LYPLAL1, MTCH2 and TFAP2B was also observed in
the hypothalamus, but the level was similar high for
MC4R, KCTD15 and BDNF in the mesenterial fat, for
LYPLAL1 and MTCH2 in the kidney fat and for TFAP2B
in the subcutaneous fat. SEC16B was the only gene,
which showed the highest expression not in the hypo-
thalamus, but in the subcutaneous fat alone. Concomi-
tant the expression of SEC16B was lowest in the
hypothalamus and kidney fat. This fact is in line with re-
cent results from the GIANT consortium, which also
found a high expression for a bigger part of the obesity-
related genes in the hypothalamus [11] and suggests a
critical role of these GWAS obesity associated genes in
the central regulation of energy balance.
Despite this fact it is very interesting that there were
no significant differences between the target genes in the
hypothalamus of ZL and ZDF rats. Differences were
observed in the kidney fat, where the expression of
LYPLAL1, TFAP2B, NEGR1, SEC16B and FAIM2 was
significantly lower in the ZDF rats. Additionally for
NEGR1 a significantly lower expression was found in all
three adipose tissues of ZDF rats and for MTCH2 a sig-
nificantly higher expression was found in the subcutane-
ous and mesenterial fat of ZDF rats. This suggests thatputative important mechanisms of the obesity associated
genes in the hypothalamus are not responsible for the
development of obesity in ZDF rats. Instead changes in
the adipose tissue seem to be accountable for the devel-
opment of the ZDF phenotype.
Taking further into account that ZDF rats exhibit
hyperleptinemia (see Table 2) due to a defect in the lep-
tin receptor, we can assume that the actions of those
genes without differential expressions between ZL and
ZDF rats must be rather independent of leptin levels or
its effects.Limitations
This study has certain limitations. Our study was
planned as a descriptive expression analysis of fourteen
novel obesity related genes in the animal model of the
ZDF rat. Thereby, the aim was on the one hand to iden-
tify tissues, in which those genes are expressed, and on
the other hand, to reveal differences in the expression
levels between ZDF rats and their littermates the ZL rats
at an age of 22 weeks. Therefore, this study does not
provide information on alterations in different fasting
states of the animals, but this might be of interest for fu-
ture work considering the fact that a high fat diet is
known to induce alterations in metabolism and gene ex-
pression of adipose tissues [40]. Furthermore as a sole
descriptive study in a certain animal model, our results
are not simply assignable to other animal models of
obesity. This is particularly because ZDF rats are not
only obese, but also develop Typ 2 diabetes mellitus.
That is why, we cannot exclude that the observed altera-
tions in the gene expression could at least in part be
related to the diabetic state of the animals. Additionally,
it has to be mentioned, that ZDF rats are homozygous
for a defect in the leptin receptor and it is not clear,
whether this alone causes alterations in the expression of
the investigated obesity genes. The possible impact of in-
sulin resistance and leptin receptor defect could be fur-
ther investigated by studying Spontaneously Diabetic
Torii (SDT) rats as a model of non-obese type 2 diabetes
mellitus and a congenic strain of SDT rat with the same
leptin receptor defect as the ZDF rats, which are obese
and develop type 2 diabetes mellitus [41].Conclusion
Thirteen of our fourteen investigated obesity-related
genes showed the highest expression in the hypothal-
amus suggesting a role of these genes predominantly in
the central regulation of energy homeostasis. On the
other hand the ZDF phenotype accompanies only with
expression changes in the adipose tissues, which implies
that peripheral mechanisms are important for the devel-
opment of obesity in ZDF rats. However, further studies
Schmid et al. Cardiovascular Diabetology 2012, 11:48 Page 10 of 11
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necessary.
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